el documento - Biblioteca Digital FCEN UBA - Universidad de ...

[245] Shimizu T, Jiang JY, Sasada H, Sato E. Changes of messenger RNA expression of angiogenic
factors and related receptors during follicular development in gilts. Biol. Reprod. 2002; 67:
1846-1852.
[246] Barboni B, Turriani M, Galeati G, Spinaci M, Bacci ML, Forni M, Mattioli M. Vascular
endothelial growth factor production in growing pig antral follicles. Biol Reprod. 2000; 63:
858-864.
[247] Laitinen M, Ristimaki A, Honkasalo M, Narko K, Paavonen K, Ritvos O. Differential
hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C
messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology
1997; 138: 4748-4756.
[248] Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN. Regulation of
vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and
beta. Proc. Natl. Acad. Sci. U. S. A 2000; 97: 10972-10977.
[249] Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGF-receptor signal transduction.
Trends Biochem. Sci. 2003; 28: 488-494.
[250] Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr.
Rev. 2004; 25: 581-611.
[251] Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia
may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
[252] Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte
MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD. Angiopoietin-2 is
required for postnatal angiogenesis and lymphatic patterning, and only the latter role is
rescued by Angiopoietin-1. Dev. Cell 2002; 3: 411-423.
[253] Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F, Hazzard TM. Regulation and action
of angiogenic factors in the primate ovary. Arch. Med. Res. 2001; 32: 567-575.
[254] Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D,
McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD.
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;
277: 55-60.
[255] Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD,
Isner JM. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced
postnatal neovascularization. Circ. Res. 1998; 83: 233-240.
[256] Wulff C, Wiegand SJ, Saunders PT, Scobie GA, Fraser HM. Angiogenesis during follicular
development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular
endothelial growth factor Trap(A40)). Endocrinology 2001; 142: 3244-3254.
[257] Geva E, Jaffe RB. Role of angiopoietins in reproductive tract angiogenesis. Obstet. Gynecol.
Surv. 2000; 55: 511-519.
[258] LeCouter J, Lin R, Ferrara N. Endocrine gland-derived VEGF and the emerging hypothesis of
organ-specific regulation of angiogenesis. Nat. Med. 2002; 8: 913-917.
[259] Schally AV, Arimura A, Kastin AJ, Matsuo H, Baba Y, Redding TW, Nair RM, Debeljuk L,
White WF. Gonadotropin-releasing hormone: one polypeptide regulates secretion of
luteinizing and follicle-stimulating hormones. Science 1971; 173: 1036-1038.
[260] Khosravi S, Leung PC. Differential regulation of gonadotropin-releasing hormone (GnRH)I
and GnRHII messenger ribonucleic acid by gonadal steroids in human granulosa luteal cells. J.
Clin. Endocrinol. Metab 2003; 88: 663-672.
173